false
Home
2023 AOSSM Annual Meeting Recordings with CME
Q & A: Rotator Cuff I
Q & A: Rotator Cuff I
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
So Sam and I will try to keep an eye on mics, so if somebody has a question on one of the papers, we're a little over time, so we can't do a lot, but we'll also be looking at the app, so if you send it up and or get to the mic, we'll try to get it real quick, but then we've got to move on. Connie Chu from Stanford. JT, wonderful talk on the use of an autograft. I would say it's probably highly likely that the histology underestimates the viability of the cells in your tendon samples, and just wondering what their definite benefits of using autograft and what some of the other benefits might be of using autograft. Yeah, thanks, Connie. I agree with you that we definitely need to analyze the tenosites in terms of their metabolic activity, right, as they go in. The purpose for us, though, is that any of these grafts, for example, when you put an autograft into any part of the body, they probably die, and then they get revascularized. So there is some, for sure, some issues with that, but what we wanted to know is that in the processing part of creating this patch, are we actually damaging them at that point? And from at least a macroscopic standpoint, I think we're safe there. Now, what happens to them at three days and five days and seven days, not sure, but we have a long 50-year history of tendon grafts being placed into the body with excellent reincorporation and excellent metabolic activity and healing, so pretty confident in that regard. I think the biggest advantage of this is that it's free, and so we don't have to take the $6,000 patch off the shelf or try to talk to our patients about coming up with cash to pay for these augmentation options when one's staring at us in the face and readily available. Dr. Kelly. Father, I just want to make a disclosure that John Tokish is smarter than me, but I'm going to ask him a question, JT. As I evolve in my techniques for massive cuffs, I've been using the biceps more as an autograft. So give me your take. Are you discrediting that notion, or are you just saying that these are ones that really don't need that help? Thanks, John. Two different populations. I think this is not a mechanical graft. I think the biceps SCR that's been popularized by many, including Larry Field, is an excellent operation and has really taken the allograft, but I think it proves exactly the same point. If you have an autograft source, and in that case, in the case you're using it for, an autograft biceps that you can use as SCR, it's a fantastic option, and the literature is now bearing that out. If you have a repairable cuff that you feel needs augmentation, I think that's where the indication for this may be. So thanks. Sorry to cut off, but we've got to try to stay on time, so we're going to move along. Thanks to the presenters. JT, you got off easy because I had some stuff for you, brother. And so time won't allow that, but thank you to the presenters and good papers, and we're going to move on. Thank you.
Video Summary
In this video, the speakers, Sam and JT, discuss the use of autografts in tendon samples. Connie Chu from Stanford asks about the viability and benefits of using autografts. JT agrees that the tenosites need further analysis in terms of metabolic activity. He explains that while there may be some issues with the autografts dying and then getting revascularized, the process of creating the patch does not seem to damage them. JT also mentions the long history of successful tendon grafts and the advantage of autografts being free. Another speaker, Dr. Kelly, asks about using the biceps as an autograft for massive cuffs, to which JT responds that different populations require different approaches. The video concludes by thanking the presenters and urging to stay on time. No credits were mentioned.
Asset Caption
Mikalyn DeFoor, MD; John Tokish, MD; Forsythe Group
Keywords
autografts
tendon samples
viability
benefits
metabolic activity
×
Please select your language
1
English